首页 > 市场调查报告书 > 製药

以基因为基之药物开发

市场调查报告书

商品编码

1533601

蛋白质体学市场规模、份额和成长分析：按仪器技术、按试剂、按应用、按地区 - 产业预测，2024-2031

Proteomics Market Size, Share, Growth Analysis, By Instrumentation Technology, By Reagent, By Application, By Region - Industry Forecast 2024-2031

出版日期: 2024年08月04日 | 出版商:

SkyQuest | 英文 157 Pages | 商品交期: 3-5个工作天内

价格

简介目录

2022年全球蛋白质体学市场规模将为252亿美元，从2023年的293.5亿美元成长到2031年的1001.7亿美元，在预测期间（2024-2031年）预计复合年增长率为16.55%。

根据SkyQuest分析，全球将有1930万新癌症病例和1000万癌症相关死亡。心血管疾病（CVD）仍然是全世界死亡的主要原因之一。根据世界卫生组织 (WHO) 的报告，每年有 4,100 万人死于这些疾病。因此，危及生命的疾病的盛行率不断增加，增加了对个人化治疗的需求，并对产业产生了积极影响。癌症、心血管疾病、呼吸系统疾病和慢性肾臟病（CKD）等慢性病盛行率的增加预计也将推动市场成长。研发投资的增加也是关键驱动因素。美国国立卫生研究院 (NIH) 开展了 370 个生物医学研究项目，以支持旨在阐明基本疾病过程的生命科学研究，包括识别生物标记和致病基因/蛋白质，我们已拨款 10 亿美元。此外，诺和诺德基金会还津贴高达 150 万美元，在哥本哈根大学建立质谱设施，这是蛋白质研究的重大进展。随着活动从大流行造成的破坏中恢復，全球蛋白质体市场预计将获得动力。

市场概况
光谱学
- 质谱分析
- 核磁共振波谱
- 圆二色光谱法
层析法
- HPLC
- 离子层析法
- 亲和层析法
- 超临界流体层析
电泳
- 凝胶电泳
- 毛细管电泳
蛋白质微阵列
- 生物晶片
- 实验室晶片
- 蛋白质晶片
- 微阵列设备
- 综合系统
- 微阵列扫描仪
- 阿莱亚
X射线结晶结构分析
表面等离子体共振
蛋白质部分
其他技术

蛋白质体学市场：按试剂分类

市场概况
免疫检测试剂
光谱试剂
层析法
蛋白质微阵列试剂
X射线结晶结构分析试剂
电泳试剂
蛋白质分级分离试剂
其他试剂

蛋白质体学市场：依服务/软体分类

市场概况
核心蛋白质体学服务
- 蛋白质鑑定服务
- 蛋白质表征服务
- 定量蛋白质体学服务
- 蛋白质精製服务
- 蛋白质分离服务
- 蛋白质序列分析服务
- 客自订化验服务
生物资讯软体和服务
- 生物资讯服务
- 生物资讯学工具
- 生物资讯资料库
光子网路
其他技术

蛋白质体学市场：依应用分类

市场概况
临床诊断
- 癌症
- 感染疾病
- 糖尿病
- 神经系统疾病
- 自体免疫疾病
- 心血管疾病
- 其他临床诊断应用
药物发现/开发
- 目标发现
- 线索识别
- 临床前研究
其他应用

蛋白质体学市场：依最终用户分类

市场概况
医院
临床实验室
製药和生物技术公司
学术实验室
其他最终用户

蛋白质体学市场规模：按地区划分

市场概况
北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 其他欧洲国家地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 其他亚太地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲 (MEA)
- 海湾合作委员会国家
- 南非
- 其他中东/非洲地区

竞争格局

前5名企业对比
主要企业市场定位（2023年）
主要市场参与者所采取的策略
近期市集活动
主要企业市场占有率（2023年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Bio-Rad Laboratories, Inc.（US）
Merck KGaA（Germany）
Agilent Technologies, Inc.（US）
Bruker Corporation（US）
Danaher Corporation（US）
GE Healthcare（US）
PerkinElmer Inc.（US）
Waters Corporation（US）
Illumina, Inc.（US）
Eurofins Scientific（Luxembourg）
QIAGEN Bioinformatics（Netherlands）
Creative Proteomics（US）
Promega Corporation（US）
Sengenics（Singapore）
Biomax Informatics AG（Germany）
MS Bioworks LLC（US）
WuXi NextCODE（China）
Fios Genomics Ltd.（UK）
Biognosys AG（Switzerland）
Bioproximity（Switzerland）
MRM Proteomics Inc.（Canada）

简介目录

Product Code: SQMIG35G2281

Global Proteomics Market size was valued at USD 25.2 billion in 2022 and is poised to grow from USD 29.35 billion in 2023 to USD 100.17 billion by 2031, growing at a CAGR of 16.55% in the forecast period (2024-2031).

According to SkyQuest's analysis, there will be 19.3 million new cancer cases worldwide and 10 million cancer-related deaths. Cardiovascular diseases (CVDs) remain one of the leading causes of death globally. The World Health Organization (WHO) reports that target diseases kill 41 million people annually. Consequently, the rising prevalence of life-threatening diseases is driving the demand for personalized therapies, positively impacting the industry. The growing prevalence of chronic diseases such as cancer, CVDs, respiratory diseases, and chronic kidney disease (CKD) is also expected to fuel market growth. Increased investments in proteomics research and development are another key growth driver. The National Institutes of Health (NIH) in the United States allocated $37 billion for biomedical research, aiming to support life sciences research that seeks to understand fundamental disease processes, such as identifying biomarkers and the genes/proteins responsible for diseases. Additionally, the Novo Nordisk Foundation awarded the University of Copenhagen a grant of up to $1.5 million to establish a mass spectrometry facility, advancing protein research significantly. The Global Proteomics Market is expected to gain momentum as activities resume following the disruptions caused by the pandemic.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Proteomics market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Proteomics Market Segmental Analysis

The global proteomics market is segmented based on the Instrumentation Technology, Reagent, Software &Services, Application, End User and Region. Based on the Instrumentation Technology, the market is segmented into Services, Reagents & Consumables, and Instruments. Based on Reagent, the market is segmented into Immunoassay Reagents, Spectroscopy Reagents, Chromatography Reagents, Protein Microarray Reagents, X-Ray Crystallography Reagents, Electrophoresis Reagents, Protein Fractionation Reagents, Other Reagents. Based on Software & Services, the market is segmented into Core Proteomics Services (Protein Identification Services, Protein Characterization Services, Quantitative Proteomics Services, Protein Purification Services, Protein Separation Services, Protein Sequencing Services, Custom Assay Services), Bioinformatics Software & Services (Bioinformatics Services, Bioinformatics Tools, Bioinformatics Databases), Photonic Network, Other Technologies. Based on Application, the market is segmented into Clinical Diagnostics (Cancer, Infectious Diseases, Diabetes, Neurological Disorders, Autoimmune Diseases, Cardiovascular Diseases, Other Clinical Diagnostic Applications), Drug Discovery & Development (Target Discovery, Lead Identification, Preclinical Studies), and Other Applications. Based on End User, the market is segmented into Hospitals, Clinical Laboratories, Pharmaceutical & Biotechnology Companies, Academic Research Laboratories, and Other End Users. Based on Region, the market is segmneted into North America, Europe, Asia-Pacific, Latin America, and Middle East and Africa.

Drivers of the Global Proteomics Market

The growth of the proteomics market is driven by advancements in technologies such as mass spectrometry and complex chromatography, which enhance the precision and speed of protein analysis. These innovations facilitate the identification and quantification of proteins, thereby expanding the application of proteomics in areas such as drug discovery, diagnostics, and clinical settings.

Restraints in the Global Proteomics Market

A challenge associated with proteomic data analysis is its inherent complexity. The process of examining proteomic data can be time-consuming, labor-intensive, and often requires extensive tools, as well as significant time and expertise to operate these tools effectively. This complexity can slow down the research process and potentially diminish the benefits of proteomics for both clinical and research applications.

Market Trends of the Global Proteomics Market

Nano proteomics has emerged from the integration of proteomics technologies with nanotechnology. This field leverages various nano-based approaches, including phosphor proteomics with metal oxide nanoparticles, protein microarrays, and nanostructured surfaces for protein and biomarker detection. Nano proteomics combines traditional proteomics techniques with nanotechnology applications, such as nanoporous structures, functionalized nanoparticles, quantum dots, and polymeric nanostructures, to enhance analytical capabilities and improve detection and separation of proteins.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Pricing Analysis
Value Chain Analysis
Supply chain Analysis
Ecosystem of the Market
Trade Analysis
Patent Analysis
Customer & Buying Criteria Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Market Attractive Index
Degree of Competition

Proteomics Market by Instrumentation Technology

Market Overview
Spectroscopy
- Mass Spectroscopy
- NMR Spectroscopy
- CD Spectroscopy
Chromatography
- HPLC
- Ion Chromatography
- Affinity Chromatography
- Supercritical Fluid Chromatography
Electrophoresis
- Gel Electrophoresis
- Capillary Electrophoresis
Protein Microarrays
- Biochips
- Lab-on-chips
- Protein chips
- Microarray Instruments
- Integrated systems
- Microarray scanners
- Arrayers
X-Ray Crystallography
Surface Plasmon Resonance
Protein Fractionation
Other Technologies

Proteomics Market by Reagent

Market Overview
Immunoassay Reagents
Spectroscopy Reagents
Chromatography Reagents
Protein Microarray Reagents
X-Ray Crystallography Reagents
Electrophoresis Reagents
Protein Fractionation Reagents
Other Reagents

Proteomics Market by Service & Software

Market Overview
Core Proteomics Services
- Protein Identification Services
- Protein Characterization Services
- Quantitative Proteomics Services
- Protein Purification Services
- Protein Separation Services
- Protein Sequencing Services
- Custom Assay Services
Bioinformatics Software & Services
- Bioinformatics Services
- Bioinformatics Tools
- Bioinformatics Databases
Photonic Network
Other Technologies

Proteomics Market by Application

Market Overview
Clinical Diagnostics
- Cancer
- Infectious Diseases
- Diabetes
- Neurological Disorders
- Autoimmune Diseases
- Cardiovascular Diseases
- Other Clinical Diagnostic Applications
Drug Discovery & Development
- Target Discovery
- Lead Identification
- Preclinical Studies
Other Applications

Proteomics Market by End-User

Market Overview
Hospitals
Clinical Laboratories
Pharmaceutical & Biotechnology Companies
Academic Research Laboratories
Other End Users

Proteomics Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2023
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2023

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Merck KGaA (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agilent Technologies, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bruker Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Danaher Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
GE Healthcare (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Waters Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Illumina, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Eurofins Scientific (Luxembourg)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
QIAGEN Bioinformatics (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Creative Proteomics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Promega Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Sengenics (Singapore)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biomax Informatics AG (Germany)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MS Bioworks LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
WuXi NextCODE (China)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Fios Genomics Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Biognosys AG (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bioproximity (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
MRM Proteomics Inc. (Canada)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments